These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1099 related articles for article (PubMed ID: 32330203)
1. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713 [TBL] [Abstract][Full Text] [Related]
3. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450 [TBL] [Abstract][Full Text] [Related]
4. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism. Cao C; Wang C Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720 [TBL] [Abstract][Full Text] [Related]
6. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma. Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma. Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802 [No Abstract] [Full Text] [Related]
8. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein. Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313 [TBL] [Abstract][Full Text] [Related]
9. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. Zhu HT; Dong QZ; Sheng YY; Wei JW; Wang G; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX PLoS One; 2012; 7(12):e52393. PubMed ID: 23285022 [TBL] [Abstract][Full Text] [Related]
11. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560 [TBL] [Abstract][Full Text] [Related]
12. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma. Zhang X; Li W; Li S; Zhang Z; Song W Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442 [TBL] [Abstract][Full Text] [Related]
13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
14. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus. Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820 [TBL] [Abstract][Full Text] [Related]
18. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
19. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238 [TBL] [Abstract][Full Text] [Related]
20. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]